CHU de Quebec Universite de Laval ( Site 0013)

Québec, Quebec G1R 2J6

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Solid Tumors

Studies at this site

• Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001) — Stopped early